DE69232207D1 - Konditionierte wasserlösliche Substanzen - Google Patents

Konditionierte wasserlösliche Substanzen

Info

Publication number
DE69232207D1
DE69232207D1 DE69232207T DE69232207T DE69232207D1 DE 69232207 D1 DE69232207 D1 DE 69232207D1 DE 69232207 T DE69232207 T DE 69232207T DE 69232207 T DE69232207 T DE 69232207T DE 69232207 D1 DE69232207 D1 DE 69232207D1
Authority
DE
Germany
Prior art keywords
water soluble
soluble substances
conditioned water
vacuum
micronised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232207T
Other languages
English (en)
Other versions
DE69232207T2 (de
Inventor
Katarina Ulla Bystroem
Edib Jakupovic
Jan William Trofast
Eva Ann-Christin Trofast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69232207(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69232207D1 publication Critical patent/DE69232207D1/de
Application granted granted Critical
Publication of DE69232207T2 publication Critical patent/DE69232207T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paper (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treating Waste Gases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Cosmetics (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69232207T 1991-04-11 1992-03-24 Konditionierte wasserlösliche Substanzen Expired - Lifetime DE69232207T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (2)

Publication Number Publication Date
DE69232207D1 true DE69232207D1 (de) 2001-12-20
DE69232207T2 DE69232207T2 (de) 2002-08-01

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69232207T Expired - Lifetime DE69232207T2 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche Substanzen
DE69210601T Expired - Lifetime DE69210601T2 (de) 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69210601T Expired - Lifetime DE69210601T2 (de) 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen

Country Status (28)

Country Link
US (1) US5562923A (de)
EP (3) EP0680752B1 (de)
JP (2) JP3400999B2 (de)
KR (1) KR100216384B1 (de)
AT (2) ATE208613T1 (de)
AU (1) AU662519B2 (de)
BG (1) BG61474B1 (de)
CA (1) CA2106975C (de)
CZ (1) CZ286936B6 (de)
DE (2) DE69232207T2 (de)
DK (2) DK0680752T3 (de)
EE (1) EE02970B1 (de)
ES (2) ES2168322T3 (de)
FI (1) FI105388B (de)
GR (1) GR3020602T3 (de)
HK (1) HK52497A (de)
HU (1) HU211116B (de)
IE (1) IE921144A1 (de)
IS (1) IS3834A (de)
NO (1) NO311867B1 (de)
PL (1) PL168232B1 (de)
PT (1) PT680752E (de)
RO (1) RO115779B1 (de)
RU (1) RU2112507C1 (de)
SE (1) SE9101090D0 (de)
SG (1) SG43180A1 (de)
SK (1) SK280310B6 (de)
WO (1) WO1992018110A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
EP0812195B1 (de) 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Arzneizubereitungen für piperidinalkanolderivate
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP0969816B1 (de) * 1997-03-20 2004-12-15 Schering Corporation Herstellung von pulveragglomeraten
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
DE69814428T2 (de) * 1997-09-29 2004-05-13 Nektar Therapeutics, San Carlos In verneblern verwendbare, stabilisierte zubereitungen
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826284D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826286D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
WO2004087102A2 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
EP1820494B1 (de) * 2003-06-13 2010-01-13 Skendi Finance, Ltd. Mikrosphären von Estradiol und Cholesterol
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
CN1894095A (zh) * 2003-10-17 2007-01-10 纳幕尔杜邦公司 箔对热塑性聚合物的粘合
CA2554927A1 (en) 2004-02-03 2005-08-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
CN101896162B (zh) * 2007-12-13 2013-06-05 诺瓦提斯公司 有机化合物
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
JP2014527955A (ja) 2011-06-29 2014-10-23 アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ 糖質コルチコイド介在性障害の処置のための、インダゾリルアミド誘導体の結晶形
JP6454323B2 (ja) * 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
JPH08186B2 (ja) * 1985-06-21 1996-01-10 ゲルゲリイ、ゲルハルト プロセス材料から反応生成物を製造する方法及びその装置
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
EP0680752A2 (de) 1995-11-08
RO115779B1 (ro) 2000-06-30
SK108893A3 (en) 1994-03-09
FI934429A (fi) 1993-10-08
DE69210601T2 (de) 1996-10-02
US5562923A (en) 1996-10-08
ES2168322T3 (es) 2002-06-16
EP0680752B1 (de) 2001-11-14
AU1534792A (en) 1992-11-17
ATE137671T1 (de) 1996-05-15
ATE208613T1 (de) 2001-11-15
HU9302870D0 (en) 1993-12-28
WO1992018110A1 (en) 1992-10-29
HUT65095A (en) 1994-04-28
SK280310B6 (sk) 1999-11-08
EP0580648A1 (de) 1994-02-02
EP0680752A3 (de) 1995-11-22
FI934429A0 (fi) 1993-10-08
HU211116B (en) 1995-10-30
RU2112507C1 (ru) 1998-06-10
BG98147A (bg) 1994-12-02
NO933575L (no) 1993-10-06
BG61474B1 (en) 1997-09-30
FI105388B (fi) 2000-08-15
DK0680752T3 (da) 2002-02-25
HK52497A (en) 1997-05-02
EE02970B1 (et) 1997-04-15
DE69210601D1 (de) 1996-06-13
NO933575D0 (no) 1993-10-06
NO311867B1 (no) 2002-02-11
JPH06506454A (ja) 1994-07-21
EP0580648B1 (de) 1996-05-08
IE921144A1 (en) 1992-10-21
PL168232B1 (pl) 1996-01-31
IS3834A (is) 1992-10-12
JP3400999B2 (ja) 2003-04-28
GR3020602T3 (en) 1996-10-31
CZ286936B6 (cs) 2000-08-16
SG43180A1 (en) 1997-10-17
EP0508969A1 (de) 1992-10-14
AU662519B2 (en) 1995-09-07
DK0580648T3 (da) 1996-09-16
CA2106975C (en) 2002-03-19
ES2086733T3 (es) 1996-07-01
SE9101090D0 (sv) 1991-04-11
KR100216384B1 (ko) 1999-08-16
DE69232207T2 (de) 2002-08-01
PT680752E (pt) 2002-05-31
CZ211693A3 (en) 1994-04-13
JP2003155228A (ja) 2003-05-27
CA2106975A1 (en) 1992-10-12

Similar Documents

Publication Publication Date Title
DE69232207D1 (de) Konditionierte wasserlösliche Substanzen
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
CA2211600A1 (en) Apparatus for and method of testing leakage of hollow member
DE69106828D1 (de) Antimykotische Zusammensetzung in Trocken Aerosol Form.
ES2144868T3 (es) Metodo de tratamiento de superficie por via seca y dispositivo para la aplicacion de un metodo asi.
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
NL184938C (nl) Adiabatische drukschommelingsadsorptie voor het fractioneren van lucht, alsmede een inrichting hiervoor.
SE8406387D0 (sv) Sperrhjulsanordning
JPS5259212A (en) Vehicle use air cleaner
JPS5311226A (en) Air fuel ratio sensor for exhaust gas
JPS5250481A (en) Air cylinder
SU594679A1 (ru) Устройство дл пневматическогоТРАНСпОРТиРОВАНи гРузОВ
SE8901541D0 (sv) Skjutbana
Goldstein The CFC issue: Refrigerant substitutes.
JPS6440922A (en) Dew condensation preventing method for optical unit
JPS51120504A (en) Pneumatic tire
ES218807U (es) Saco-camilla de vacio, para inmovilizacion, proteccion y transporte de personas y objetos.
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
JPS528670A (en) Organic solvent vapor degreasing tabk
JPS549584A (en) X-ray exposure device
ES261780A1 (es) Dispositivo para el salvamento de personas y objetos en casos de incendio en edificios
ES239975U (es) Dispositivo para el armado de habitaculos portatiles
JPS51137073A (en) A liquid pressure control apparatus
JPS51120424A (en) Joint for ducts or the like
BR7401345U (pt) Recipiente hermético provido de um sistema de carga e descarga regulável

Legal Events

Date Code Title Description
8363 Opposition against the patent